Together we will beat cancer

Donate now

Melanoma

Melanoma is a type of skin cancer that develops from cells called melanocytes. It’s the 5th most common cancer in the UK, with around 16,200 new cases of melanoma in the UK each year.
Showing 12 out of 119 results

Melanoma skin cancer cases in the UK have reached an all-time high according to new analysis released today from Cancer Research UK. Melanoma skin cancer cases in the UK have reached an all-time high according to new analysis released today from Cancer Research UK.

by Sophie Wedekind | News | 7 July 2023

7 July 2023

An elderly male patient sat on a hospital bed

Ageing is often the ‘forgotten’ cancer risk factor, overshadowed by preventable risk factors like smoking and obesity. Now, Cancer Grand Challenges are bringing bringing the ‘forgotten’ cancer risk factor into the spotlight.  Ageing is often the ‘forgotten’ cancer risk factor, overshadowed by preventable risk factors like smoking and obesity. Now, Cancer Grand Challenges are bringing bringing the ‘forgotten’ cancer risk factor into the spotlight. 

by Jacob Smith | In depth | 29 May 2023

29 May 2023

Melanoma cells viewed under the microscope

New results from the Cancer Research UK-funded PEACE study have revealed how some skin cancers stop responding to treatment at the end of life. New results from the Cancer Research UK-funded PEACE study have revealed how some skin cancers stop responding to treatment at the end of life.

by Jacob Smith | News | 29 March 2023

29 March 2023

A photograph of a family walking their dog in the shade.

Skin cancer death rates in UK men have more than tripled since the early 1970s, according to new analysis released today by Cancer Research UK. Skin cancer death rates in UK men have more than tripled since the early 1970s, according to new analysis released today by Cancer Research UK.

by Lilly Matson | News | 15 July 2022

15 July 2022

Melanoma cell. Credit: Dr Erik Sahai

The National Institute for Health and Care Excellence has recommended the use of the immunotherapy drug pembrolizumab (Keytruda) for some adults in England with a type of advanced melanoma skin cancer. The National Institute for Health and Care Excellence has recommended the use of the immunotherapy drug pembrolizumab (Keytruda) for some adults in England with a type of advanced melanoma skin cancer.

by Harry Jenkins | News | 21 December 2021

21 December 2021

Cancer Research UK scientists have developed a new way to analyse blood for evidence of cancer that could be up to ten times more sensitive than previous methods. Cancer Research UK scientists have developed a new way to analyse blood for evidence of cancer that could be up to ten times more sensitive than previous methods.

by Alex Lathbridge | Analysis | 18 June 2020

18 June 2020

Skin cancer cells under an electron microscope.

An immunotherapy and a targeted cancer drug were among the latest batch of NHS approvals from the Scottish Medicines Consortium (SMC).  An immunotherapy and a targeted cancer drug were among the latest batch of NHS approvals from the Scottish Medicines Consortium (SMC). 

by Cancer Research UK | News | 12 February 2020

12 February 2020

Babraham Institute group leader Dr Simon Cook and PhD student Emma Minihane discuss research results in the lab as part of the continuation of this research in the Cook lab. Image credit: the Babraham Institute.

Researchers have demonstrated an approach which, used in parallel with existing treatments, wipes out the ‘survival system’ of cancer cells. Researchers have demonstrated an approach which, used in parallel with existing treatments, wipes out the ‘survival system’ of cancer cells.

by Cancer Research UK | News | 14 November 2019

14 November 2019

Electron microscopy image of a skin cancer cell

Vitamin D influences the behaviour of melanoma cells in the lab by making them less aggressive, Cancer Research UK scientists have found. Vitamin D influences the behaviour of melanoma cells in the lab by making them less aggressive, Cancer Research UK scientists have found.

by Cancer Research UK | News | 6 November 2019

6 November 2019